Suzhou Net Income From Continuing Ops from 2010 to 2025

688137 Stock   35.51  0.25  0.71%   
Suzhou Novoprotein's Net Income From Continuing Ops is decreasing over the years with slightly volatile fluctuation. Net Income From Continuing Ops is expected to dwindle to about 11 M. From 2010 to 2025 Suzhou Novoprotein Net Income From Continuing Ops quarterly data regression line had arithmetic mean of  74,288,846 and r-squared of  0.20. View All Fundamentals
 
Net Income From Continuing Ops  
First Reported
2010-12-31
Previous Quarter
11.6 M
Current Value
11 M
Quarterly Volatility
35 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Suzhou Novoprotein financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Suzhou Novoprotein's main balance sheet or income statement drivers, such as Net Interest Income of 32.4 M, Interest Income of 36.8 M or Interest Expense of 2.9 M, as well as many indicators such as . Suzhou financial statements analysis is a perfect complement when working with Suzhou Novoprotein Valuation or Volatility modules.
  
This module can also supplement various Suzhou Novoprotein Technical models . Check out the analysis of Suzhou Novoprotein Correlation against competitors.

Currently Active Assets on Macroaxis

Other Information on Investing in Suzhou Stock

Suzhou Novoprotein financial ratios help investors to determine whether Suzhou Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Suzhou with respect to the benefits of owning Suzhou Novoprotein security.